To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers
Clinical trial NCT03543137 · COMPLETED
Trial details
- NCT number
- NCT03543137
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-18
- Primary completion
- 2018-11-12
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.